Allen Mooney & Barnes Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
SAM
Allen Mooney & Barnes Investment Advisors's BMY Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, selling an estimated $53.1K and leaving 33,051 shares worth $1.9M. The position accounts for 0.29% of the portfolio, ranked #56.
Allen Mooney & Barnes Investment Advisors first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.21M in Q2 2022. 1,390 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors held 33,051 shares of Bristol-Myers Squibb worth $1.9M as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors sold 924 Bristol-Myers Squibb shares in Q2 2026, an estimated $53.1K.
- Bristol-Myers Squibb made up 0.29% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #56 holding.
- Allen Mooney & Barnes Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
- Allen Mooney & Barnes Investment Advisors's Bristol-Myers Squibb position peaked at $3.21M in Q2 2022.
- 1,390 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.